Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
See here:-
https://www.lse.co.uk/rns/AGL/new-commercial-agreement-with-large-pharma-gvzk9wgh1la0ljx.html
Https://www.washingtonpost.com/world/2024/05/02/israel-hamas-war-news-gaza-palestine/
Mesquida.
"Surely 37p was the top ofbthe January spoke ?2
======================================
Sorry. My memory said 51p but checking the chart it was arounf 31p! Still over two fold the currect sp of course.
One would have thought. We will see. Like the odds and potential 100% plus profit myself!
All IMHO.
Nudgesta.
"The sp has never been that low??"
======================
Results due this month.
Lowest I remember was about 9.8p Nov 2023. Highest since then 51p ish (spike up due to RNS of 4th Jan 2024 - Cancer breakthrough). Recently spiked to 17p (contract with Astrazeneca). Illiquid share means it moves a lot on low volume (either way). Thus a good news RNS often spikes the sp up a lot.......
Currently 14p.
All IMHO.
I would not be surprised is a bid comes in.
A leading liquid biopsy Company with an FDA cleared machine, contracts with both Eisai and now Astrazeneca........
The market cap is ridiculous if you ask me.
All IMHO.
Due this month.
The original announcement "ANGLE announces partnership with BioView" 19th April 2023:-
https://www.lse.co.uk/rns/AGL/angle-announces-partnership-with-bioview-dvvtkgt3ttabibt.html
The update "Parsortix HER2 assay showcased at AACR 2024" 8th April 2024:
https://www.lse.co.uk/rns/AGL/parsortix-her2-assay-showcased-at-aacr-2024-4k393y7ivsvtwno.html
Due this month - May 2024.
See:-
https://angleplc.com/information-for-investors-angle-plc/financial-reports/#text_grid-1
TwoGood2Die.
I don't mean for the whole Company. LOL!
Hello.
Https://www.lse.co.uk/ShareBrokerTips.html?shareprice=AGL&share=Angle
Https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.34978
Just look at the Companies mentioned in this article:-
***Elena Ioana Braicu receives research funding from Bayer, Roche Diagnostics, Tesaro, GSK, and AstraZeneca and personal fees from AstraZeneca, Clovis, GSK, Tesaro, EISAI, RochePharma, and Roche Diagnostics. Elena Ioana Braicu is a Feodor Lynen fellow of the Humboldt Foundation and a participant in the Charité Clinical Scientist Program funded by the Charité Universitätsmedizin Berlin and the Berlin Institute of Health.
***Philipp Harter receives research funding from Astra Zeneca, Roche, GSK, Genmab, DFG, European Union, DKH, Immunogen, Seagen, Clovis, and Novartis and honoraria from Amgen, Astra Zeneca, GSK, Roche, Sotio, Stryker, Zai Lab, MSD, Clovis, Eisai, Mersana, and Exscientia.
***Philipp Harter is ******an advisory board member******* for Astra Zeneca, Roche, GSK, Clovis, Immunogen, MSD, Miltenyi, Novartis, and Eisai!!!!!!!!!!!!!!!*************.
All IMHO.
Hello.
Hello.
A fortune!
The big Co's shorting could go from a massive profit now to losing. They must be tempted to cash in their winnings to be on the safe side.
One wonders what others are in the pipeline.
There are thousands of Pharma Co's IN THE WORLD. Food for thought TwoGood2Die, is it not!!! LOL!
I think there will be LOADS in the next 4 months. LOADS.
All IMHO.
Angle now have both Eisia In. (top 100 Japanese Co) and Astrazeneca (FTSE 100 Co.) on their books.
Acorns grow to oak trees............
Where did you get the $232 billion from! Thin air?
IMHO the sp should be 18p+, absolute minimum. The bottom line is the Parsortix machine did not sell as well as they had hoped after FDA clearance. The problem was Angle hoped/expected the Pharma clients to do the work needed after the Parsortix machine had caught the circulating tumour cells to test. Also, this is such "cutting edge technology" that some labs simply did not have the technical knowhow to do the assays. Angle have now have a HER2 assay, a PD-L1 assay, a portrait flex assay, and a DNA Damage Response one. Also, the Portrait+ CTC kit which makes using the machine easier and standardises the stains used. These are now driving the Services side of the business which demonstrate the results the Parsortix machine can deliver, and no doubt increases sales of the Parsortix machine.
8th Apr 2024 7:00 am RNS Parsortix HER2 assay showcased at AACR 2024
https://www.lse.co.uk/rns/AGL/parsortix-her2-assay-showcased-at-aacr-2024-4k393y7ivsvtwno.html
5th Dec 2023 7:00 am RNS ANGLE launches Portrait+ CTC kit at SABCS
https://www.lse.co.uk/rns/AGL/angle-launches-portrait-ctc-kit-at-sabcs-5mzhyiaiggmk83j.html
9th Nov 2023 7:00 am RNS Launch of PD-L1 test to support cancer studies
https://www.lse.co.uk/rns/AGL/launch-of-pd-l1-test-to-support-cancer-studies-o8m4cvtjt6ft9a9.html
4th Sep 2023 7:00 am RNS ANGLE launch of Portrait Flex assay
https://www.lse.co.uk/rns/AGL/angle-launch-of-portrait-flex-assay-q8vjkxoz5ew8ywd.html
25th May 2023 7:00 am RNS Pharma services contract with Artios Pharma
https://www.lse.co.uk/rns/AGL/pharma-services-contract-with-artios-pharma-mjim4s7jtk1clj5.html
All IMHO